![]() |
Volumn 28, Issue 3, 2008, Pages 345-347
|
Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: A pilot study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RISPERIDONE;
NEUROLEPTIC AGENT;
ANXIETY;
BORDERLINE DISORDER RATING SCALE;
BORDERLINE STATE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DEPRESSION;
DIZZINESS;
DRUG WITHDRAWAL;
FATIGUE;
FEMALE;
HOSTILITY;
HUMAN;
IMPULSIVENESS;
INCREASED APPETITE;
LETHARGY;
LETTER;
MOTOR DYSFUNCTION;
MUSCLE STIFFNESS;
OPEN STUDY;
PAIN;
PARESTHESIA;
PILOT STUDY;
PRIORITY JOURNAL;
PSYCHOLOGIC ASSESSMENT;
RATING SCALE;
SIDE EFFECT;
SOMNOLENCE;
TONGUE DISEASE;
TREATMENT RESPONSE;
WEIGHT GAIN;
ADULT;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG EFFECT;
OUTCOME ASSESSMENT;
PERSONALITY TEST;
PSYCHOLOGICAL ASPECT;
PSYCHOMETRY;
QUALITY OF LIFE;
STATISTICS;
TREATMENT OUTCOME;
ADULT;
ANTIPSYCHOTIC AGENTS;
BORDERLINE PERSONALITY DISORDER;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
OUTCOME ASSESSMENT (HEALTH CARE);
PERSONALITY INVENTORY;
PILOT PROJECTS;
PSYCHOMETRICS;
QUALITY OF LIFE;
RISPERIDONE;
TREATMENT OUTCOME;
WEIGHT GAIN;
|
EID: 51449121218
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/JCP.0b013e318173083e Document Type: Letter |
Times cited : (11)
|
References (5)
|